Pegorgotein

N/A

Report date: 2023/02/18 22:36:55

Base Information

Drug NamePegorgotein
Drug Alias NamePolyethylene glycol superoxide dismutasePEG-superoxide dismutaseDismutecPEG-SODWIN-22118
ClassificationBiologics
Mechanisms of ActionOxygen radical scavengers
TargetsNot applicable
Therapy Area/IndicationsReperfusion InjuryStrokeBrain Injuries
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEnzon Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEnzon Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsReperfusion InjuryStrokeBrain Injuries

Other Information

ATC CodeN/A
Related LinksN/A